NAICS 42221 - Drugs and druggists' sundries wholesalers
This industry comprises establishments primarily engaged in wholesaling biological and medical products; botanical drugs and herbs; and pharmaceutical products intended for internal and external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
Industry trends:
The NAICS 42221 industry, which encompasses drugs and druggists' sundries wholesalers, is seeing several notable qualitative trends. Firstly, there is a significant push towards digital transformation. Companies are investing heavily in advanced technologies such as AI, machine learning, and blockchain for more efficient supply chain management and inventory control. This also includes the adoption of e-commerce platforms to streamline ordering processes and enhance customer experience.
Another trend is the increased focus on sustainability. Wholesalers are looking towards eco-friendly packaging solutions and sustainable sourcing of raw materials to meet the growing consumer and regulatory demand for greener practices. Additionally, there's a shift towards personalized medicine, driven by the rise of genomics and biotechnology, which is influencing the types of drugs being stocked and distributed.
The industry is also witnessing consolidation with mergers and acquisitions becoming more frequent. This is in response to the need for larger entities that can negotiate better pricing, offer a wider range of products, and increase their market footprints.
Looking forward, the near future forecasts point towards the continued impact of regulatory changes, especially those related to drug pricing and distribution. The market is also expected to face challenges such as supply chain disruptions caused by geopolitical tensions or pandemics. However, the overall outlook remains positive with steady growth projected, driven by demographic trends like an aging population and the ongoing demand for pharmaceutical products.
This industry is comprised of:
This report includes the ability to segment your Industry by:
- Region
- Employees
- Net Sales
- Company Age
- Total Assets
- Ownership Type
With iCFO You Get
What Is iCFO?
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Sound Business Analysis
Answers come easily with iCFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine what if scenarios and P&L impact of reducing costs or adding revenue.
Your Business’ Health In Minutes
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.